| Autor: |
Chelsea L. Hansen, Amanda Perofsky, Roy Burstein, Michael Famulare, Shanda Boyle, Robin Prentice, Cooper Marshall, Benjamin JJ McCormick, David Reinhart, Ben Capodanno, Melissa Truong, Kristen Schwabe-Fry, Kayla Kuchta, Brian Pfau, Zack Acker, Jover Lee, Thomas R. Sibley, Evan McDermot, Leslie Rodriguez-Salas, Jeremy Stone, Luis Gamboa, Peter D. Han, Jeffery S. Duchin, Alpana Waghmare, Janet A. Englund, Jay Shendure, Trevor Bedford, Helen Y. Chu, Lea M. Starita, Cécile Viboud |
| Rok vydání: |
2022 |
| Popis: |
ImportanceFew US studies have reexamined risk factors for SARS-CoV-2 positivity in the context of widespread vaccination and new variants or considered risk factors for co-circulating endemic viruses, such as rhinovirus.ObjectiveTo understand how risk factors and symptoms associated with SARS-CoV-2 test positivity changed over the course of the pandemic and to compare these to the factors associated with rhinovirus test positivity.DesignThis test-negative design study used multivariable logistic regression to assess associations between SARS-CoV-2 and rhinovirus test positivity and self-reported demographic and symptom variables over a 22-month period.SettingKing County, Washington, June 2020-April 2022Participants23,278 symptomatic individuals of all ages enrolled in a cross-sectional community surveillance study.ExposuresSelf-reported data for 15 demographic and health behavior variables and 16 symptoms.Main Outcome(s) and Measure(s)RT-PCR confirmed SARS-CoV-2 or rhinovirus infection.ResultsClose contact with a SARS-CoV-2 case (adjusted odds ratio, aOR 4.3, 95% CI 3.7-5.0) and loss of smell/taste (aOR 3.7, 95% CI 3.0-4.5) were the variables most associated with SARS-CoV-2 test positivity, but both attenuated during the Omicron period. Contact with a vaccinated case (aOR 2.4, 95% CI 1.7-3.3) was associated with a lower odds of test positivity than contact with an unvaccinated case (aOR 4.4, 95% CI 2.7-7.3). Sore throat was associated with Omicron infection (aOR 2.3, 95% CI 1.6-3.2) but not Delta. Vaccine effectiveness for participants fully vaccinated with a booster dose was 43% (95% CI 11-63%) for Omicron and 92% (95% CI 61-100%) for Delta.Variables associated with rhinovirus test positivity included age Conclusions and RelevanceEstimated risk factors and symptoms associated with SARS-CoV-2 infection have changed over time. There was a shift in reported symptoms between the Delta and Omicron variants as well as reductions in the protection provided by vaccines. Racial and socioeconomic disparities persisted in the third year of SARS-CoV-2 circulation and were also present in rhinovirus infection, although the causal pathways remain unclear. Trends in testing behavior and availability may influence these results.Key PointsQuestionWhat are the characteristics associated with SARS-CoV-2 and rhinovirus infection?FindingsIn this test-negative design study of 23,278 participants, reporting close contact with a SARS-CoV-2 case was the strongest risk factor associated with test positivity. Loss of smell and taste was associated with the Delta variant, but not the Omicron variant. Vaccination and prior infection provided greater protection against Delta infection than Omicron Infection. Young age was the strongest predictor of rhinovirus positivity. Sociodemographic disparities were present for both SARS-CoV-2 and rhinovirus.MeaningMonitoring factors associated with respiratory pathogen test positivity remains important to identify at-risk populations in the post-SARS-CoV-2 pandemic period. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
